Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer

Chitta Ranjan Patra, Resham Bhattacharya, Debabrata Mukhopadhyay, Priyabrata Mukherjee

Research output: Contribution to journalArticle

275 Citations (Scopus)

Abstract

The targeted delivery of a drug should result in enhanced therapeutic efficacy with low to minimal side effects. This is a widely accepted concept, but limited in application due to lack of available technologies and process of validation. Biomedical nanotechnology can play an important role in this respect. Biomedical nanotechnology is a burgeoning field with myriads of opportunities and possibilities for advancing medical science and disease treatment. Cancer nanotechnology (1-100 nm size range) is expected to change the very foundations of cancer treatment, diagnosis and detection. Nanomaterials, especially gold nanoparticles (AuNPs) have unique physico-chemical properties, such as ultra small size, large surface area to mass ratio, and high surface reactivity, presence of surface plasmon resonance (SPR) bands, biocompatibility and ease of surface functionalization. In this review, we will discuss how the unique physico-chemical properties of gold nanoparticles may be utilized for targeted drug delivery in pancreatic cancer leading to increased efficacy of traditional chemotherapeutics.

Original languageEnglish (US)
Pages (from-to)346-361
Number of pages16
JournalAdvanced Drug Delivery Reviews
Volume62
Issue number3
DOIs
StatePublished - Mar 8 2010

Fingerprint

Nanotechnology
Pancreatic Neoplasms
Gold
Nanoparticles
Surface Plasmon Resonance
Nanostructures
Pharmaceutical Preparations
Neoplasms
Therapeutics
Technology

Keywords

  • Anti-cancer drugs
  • AuNPs
  • Colloidal gold nanoparticles
  • Drug delivery
  • EGFR
  • Fabrication
  • Gold nanoparticles
  • Pancreatic cancer
  • Targeted therapy
  • Tyrosine kinase

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. / Patra, Chitta Ranjan; Bhattacharya, Resham; Mukhopadhyay, Debabrata; Mukherjee, Priyabrata.

In: Advanced Drug Delivery Reviews, Vol. 62, No. 3, 08.03.2010, p. 346-361.

Research output: Contribution to journalArticle

Patra, Chitta Ranjan ; Bhattacharya, Resham ; Mukhopadhyay, Debabrata ; Mukherjee, Priyabrata. / Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. In: Advanced Drug Delivery Reviews. 2010 ; Vol. 62, No. 3. pp. 346-361.
@article{a2cd1b19ed9148b8affc7754710b74c6,
title = "Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer",
abstract = "The targeted delivery of a drug should result in enhanced therapeutic efficacy with low to minimal side effects. This is a widely accepted concept, but limited in application due to lack of available technologies and process of validation. Biomedical nanotechnology can play an important role in this respect. Biomedical nanotechnology is a burgeoning field with myriads of opportunities and possibilities for advancing medical science and disease treatment. Cancer nanotechnology (1-100 nm size range) is expected to change the very foundations of cancer treatment, diagnosis and detection. Nanomaterials, especially gold nanoparticles (AuNPs) have unique physico-chemical properties, such as ultra small size, large surface area to mass ratio, and high surface reactivity, presence of surface plasmon resonance (SPR) bands, biocompatibility and ease of surface functionalization. In this review, we will discuss how the unique physico-chemical properties of gold nanoparticles may be utilized for targeted drug delivery in pancreatic cancer leading to increased efficacy of traditional chemotherapeutics.",
keywords = "Anti-cancer drugs, AuNPs, Colloidal gold nanoparticles, Drug delivery, EGFR, Fabrication, Gold nanoparticles, Pancreatic cancer, Targeted therapy, Tyrosine kinase",
author = "Patra, {Chitta Ranjan} and Resham Bhattacharya and Debabrata Mukhopadhyay and Priyabrata Mukherjee",
year = "2010",
month = "3",
day = "8",
doi = "10.1016/j.addr.2009.11.007",
language = "English (US)",
volume = "62",
pages = "346--361",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer

AU - Patra, Chitta Ranjan

AU - Bhattacharya, Resham

AU - Mukhopadhyay, Debabrata

AU - Mukherjee, Priyabrata

PY - 2010/3/8

Y1 - 2010/3/8

N2 - The targeted delivery of a drug should result in enhanced therapeutic efficacy with low to minimal side effects. This is a widely accepted concept, but limited in application due to lack of available technologies and process of validation. Biomedical nanotechnology can play an important role in this respect. Biomedical nanotechnology is a burgeoning field with myriads of opportunities and possibilities for advancing medical science and disease treatment. Cancer nanotechnology (1-100 nm size range) is expected to change the very foundations of cancer treatment, diagnosis and detection. Nanomaterials, especially gold nanoparticles (AuNPs) have unique physico-chemical properties, such as ultra small size, large surface area to mass ratio, and high surface reactivity, presence of surface plasmon resonance (SPR) bands, biocompatibility and ease of surface functionalization. In this review, we will discuss how the unique physico-chemical properties of gold nanoparticles may be utilized for targeted drug delivery in pancreatic cancer leading to increased efficacy of traditional chemotherapeutics.

AB - The targeted delivery of a drug should result in enhanced therapeutic efficacy with low to minimal side effects. This is a widely accepted concept, but limited in application due to lack of available technologies and process of validation. Biomedical nanotechnology can play an important role in this respect. Biomedical nanotechnology is a burgeoning field with myriads of opportunities and possibilities for advancing medical science and disease treatment. Cancer nanotechnology (1-100 nm size range) is expected to change the very foundations of cancer treatment, diagnosis and detection. Nanomaterials, especially gold nanoparticles (AuNPs) have unique physico-chemical properties, such as ultra small size, large surface area to mass ratio, and high surface reactivity, presence of surface plasmon resonance (SPR) bands, biocompatibility and ease of surface functionalization. In this review, we will discuss how the unique physico-chemical properties of gold nanoparticles may be utilized for targeted drug delivery in pancreatic cancer leading to increased efficacy of traditional chemotherapeutics.

KW - Anti-cancer drugs

KW - AuNPs

KW - Colloidal gold nanoparticles

KW - Drug delivery

KW - EGFR

KW - Fabrication

KW - Gold nanoparticles

KW - Pancreatic cancer

KW - Targeted therapy

KW - Tyrosine kinase

UR - http://www.scopus.com/inward/record.url?scp=76849117309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76849117309&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2009.11.007

DO - 10.1016/j.addr.2009.11.007

M3 - Article

C2 - 19914317

AN - SCOPUS:76849117309

VL - 62

SP - 346

EP - 361

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 3

ER -